Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,459 | 125,551 | 147,367 | 152,938 | 155,897 |
| Receivables | 302 | 360 | 525 | 638 | 638 |
| TOTAL | $117,049 | $126,953 | $148,951 | $154,889 | $157,685 |
| Non-Current Assets | |||||
| PPE Net | 22,787 | 23,129 | 23,473 | 23,793 | 24,179 |
| TOTAL | $22,787 | $23,129 | $23,473 | $23,793 | $24,179 |
| Total Assets | $139,836 | $150,082 | $172,424 | $178,682 | $181,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 857 | 1,535 | 1,043 | 1,431 | 1,100 |
| Accrued Expenses | 2,035 | 6,318 | 2,422 | 2,410 | 4,303 |
| TOTAL | $2,999 | $7,929 | $3,565 | $3,857 | $5,410 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,815 | 1,798 | 1,779 | 1,761 | 1,741 |
| TOTAL | $1,820 | $1,803 | $1,779 | $1,761 | $1,741 |
| Total Liabilities | $4,819 | $9,732 | $5,344 | $5,618 | $7,151 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,488 | 30,488 | 30,488 | 30,488 | 30,488 |
| Common Shares | 276,899 | 276,727 | 276,565 | 276,541 | 276,434 |
| Retained earnings | -141,882 | -136,377 | -109,485 | -103,477 | -101,721 |
| TOTAL | $135,017 | $140,350 | $167,080 | $173,064 | $174,713 |
| Total Liabilities And Equity | $139,836 | $150,082 | $172,424 | $178,682 | $181,864 |